Results 181 to 190 of about 43,287 (326)

Efficacy and Safety of Intra-Articular Botulinum Toxin A Injection for Knee Osteoarthritis

, 2023
Yoyos Dias Ismiarto, Gregorius Thomas Prasetiyo   +1 more
openalex   +1 more source

Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study assesses the 3‐month effectiveness of the calcitonin gene‐related peptide monoclonal antibody galcanezumab versus traditional oral migraine preventive medications. Background Studies comparing the effectiveness of calcitonin gene‐related peptide monoclonal antibodies versus traditional oral migraine preventive medications ...
Richard B. Lipton, Miguel J. A. Láinez, Zubair Ahmed, Carlos Vallarino, Diego Novick, Maurice Vincent, Lars Viktrup, Rebecca L. Robinson   +7 more
wiley   +1 more source

Introduction to <i>Toxins</i> Special Issue on Botulinum Toxins: New Uses in the Treatment of Diseases (2nd Edition). [PDF]

Toxins (Basel)
Luvisetto S.
europepmc   +1 more source

Variability of Botulinum Toxins: Challenges and Opportunities for the Future. [PDF]

Toxins (Basel), 2018
Rasetti-Escargueil C, Lemichez E, Popoff MR.   +2 more
europepmc   +1 more source

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary This study shows that galcanezumab is equally effective and well‐tolerated in patients aged 65 and older as in younger patients, with a higher proportion of excellent responders in older patients. Despite having more baseline headache days, older patients responded well to the treatment, with age being linked to better outcomes ...
Julia Peris‐Subiza, Víctor Obach, Daniel Guisado‐Alonso, Fernando Velasco Juanes, Rocío Álvarez Escudero, María Martín Bujanda, Sonsoles Aranceta, Aintzine Ruisánchez, Natalia Roncero, Ane Mínguez‐Olaondo, Amaya Echeverria, Alba López‐Bravo, Ángel Luis Guerrero‐Peral, David García‐Azorín, Elisa Cuadrado‐Godia, Galca‐Only Study Group, Neus Fabregat, Marta Ruibal, Izaro Kortazar Zubizarreta, Nuria Riesco, Lucia González‐Fernández, Paula Manera, Agustín Oterino Duran, Yésica González‐Osorio, Santiago Fernández‐Fernández, Juan Carlos García‐Moncó, Isabel Fernández‐Pérez, Joan Jiménez‐Balado   +27 more
wiley   +1 more source

The Esthetic Use of Botulinum Toxins in Cancer Patients: Providing a Foundation for Future Indications. [PDF]

Toxins (Basel)
Papagni M, Renga M, Mogavero S, Veronesi P, Cavallini M.   +4 more
europepmc   +1 more source

SERS-Based Immunoassays for the Detection of Botulinum Toxins A and B Using Magnetic Beads. [PDF]

Sensors (Basel), 2019
Kim K, Choi N, Jeon JH, Rhie GE, Choo J.
europepmc   +1 more source

Ultrasonography for Assessment and Intervention With Botulinum Toxin Injection for Tremors [PDF]

So-Hyun Park, Joon‐Ho Shin
openalex   +1 more source

Development of the SkinCARE Questionnaire: Measuring the impact of skin issues on psychological wellbeing in healthy populations

International Journal of Cosmetic Science, EarlyView.
The SkinCARE questionnaire is a validated tool for assessing the impact of skin condition on psychological wellbeing. The present data also suggest greater skin wellbeing is linked to lower levels of perceived stress and good sleep health. Abstract Background In recent years, the psychological dimension of skin health has attracted increasing research ...
Alice Newton‐Fenner, William M. Hirst, Jennifer Davies‐Owen, Jeremy Shen, Monique A. M. Smeets, Anna Thomas, Carl Roberts, Timo Giesbrecht   +7 more
wiley   +1 more source

Botulinum toxins for the prevention of migraine in adults. [PDF]

Cochrane Database Syst Rev, 2018
Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives N, Clarke CE, Sinclair A.   +7 more
europepmc   +1 more source